24.37
Schlusskurs vom Vortag:
$24.46
Offen:
$24.45
24-Stunden-Volumen:
362.40K
Relative Volume:
0.44
Marktkapitalisierung:
$3.00B
Einnahmen:
$1.80B
Nettoeinkommen (Verlust:
$15.62M
KGV:
203.08
EPS:
0.12
Netto-Cashflow:
$118.36M
1W Leistung:
+2.65%
1M Leistung:
-6.02%
6M Leistung:
+5.64%
1J Leistung:
+12.51%
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PRVA
Privia Health Group Inc
|
24.37 | 3.01B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
240.29 | 39.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
77.93 | 13.74B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
105.18 | 9.05B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
51.44 | 9.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.91 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
How Recent Developments Are Shaping the Investment Story for Privia Health - Yahoo Finance
A Look at Privia Health Group’s (PRVA) Valuation Following Strong Q3 Results and Cautious Guidance - Yahoo Finance
Will Privia Health Group Inc. stock deliver long term returnsQuarterly Investment Review & AI Powered Buy and Sell Recommendations - moha.gov.vn
Institution Moves: Why hedge funds are buying Privia Health Group Inc. stock2025 Winners & Losers & Free High Return Stock Watch Alerts - moha.gov.vn
Healthcare Technology for Providers Q3 Earnings: Privia Health (NASDAQ:PRVA) is the Best in the Biz - Yahoo Finance
Be Wary Of Privia Health Group (NASDAQ:PRVA) And Its Returns On Capital - Sahm
Will Privia Health Group Inc. stock reach Wall Street targetsEarnings Trend Report & High Accuracy Trade Alerts - newser.com
Can Privia Health Group Inc. stock rebound after recent weaknessPortfolio Value Summary & Weekly Stock Breakout Alerts - newser.com
Why Privia Health Group Inc. stock remains on buy listsJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Can trapped investors hope for a rebound in Privia Health Group Inc.Dividend Hike & Real-Time Stock Entry Alerts - newser.com
Multi asset correlation models including Privia Health Group Inc.Gold Moves & Growth Focused Stock Pick Reports - newser.com
Can Privia Health Group Inc. stock maintain operating margins2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
How institutional buying supports Privia Health Group Inc. stockJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Published on: 2025-11-19 03:37:59 - newser.com
Trading Systems Reacting to (PRVA) Volatility - news.stocktradersdaily.com
Using data models to predict Privia Health Group Inc. stock movementQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com
Is this a good reentry point in Privia Health Group Inc.July 2025 Analyst Calls & Expert Approved Momentum Ideas - newser.com
Full technical analysis of Privia Health Group Inc. stockJuly 2025 Movers & Technical Pattern Based Buy Signals - newser.com
How sustainable is Privia Health Group Inc. stock dividend payoutProfit Target & Safe Capital Growth Plans - newser.com
Tick level data insight on Privia Health Group Inc. volatility2025 Valuation Update & Precise Buy Zone Tips - newser.com
How Privia Health Group Inc. stock performs in high volatility marketsJuly 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
How to manage a losing position in Privia Health Group Inc.2025 Retail Activity & Low Drawdown Trading Techniques - newser.com
Published on: 2025-11-14 03:13:09 - newser.com
JP Morgan Maintains Privia Health Group (PRVA) Overweight Recommendation - MSN
Privia Health Group, Inc. (PRVA) Stock Forecasts - Yahoo Finance
BMO Capital Initiates Coverage on Privia Health With Outperform Rating, $30 Price Target - MarketScreener
Solid Earnings Reflect Privia Health Group's (NASDAQ:PRVA) Strength As A Business - Yahoo Finance
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):